1. Affinitor European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/afinitor. Retrieved 5 May 2019.
2. Affinitor (Everolimus) FDA Approval History – Drugs.com. https://www.drugs.com/history/afinitor.html. Retrieved 5 May 2019.
3. Affinitor Everolimus European Medicines Agency. Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/afinitor-epar-product-information_en.pdf. Retrieved 5 May 2019.
4. Aicher LD. Tuberin phosphorylation regulates its interaction with Hamartin. J Biol Chem. 2001;276(24):21017–21.
5. Approval FDA. Everolimus Zortress Prophylaxis of organ rejection in adult patients at low – moderate immunologic risk receiving a kidney transplant; 20 Apr 2010. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/021560s000ltr.pdf. Retrieved 5 May 2019.